ProFuse Technology is pleased to announce the appointment of Professor Shulamit Levenberg, a highly distinguished expert in tissue engineering, to its Scientific Advisory Board.
Professor Levenberg’s addition strengthens ProFuse’s commitment to advancing muscle cultivation solutions for the development of innovative muscle therapeutics.
“Muscle associated diseases such as muscle wasting poses a growing health challenge,” says Professor Eldad Tzahor, ProFuse’s Scientific Founder and Board Member. “We are thrilled to welcome Professor Levenberg’s to our Scientific Advisory Board, in order to bolster our pioneering innovative approaches towards muscle regeneration and maintenance.”
Professor Levenberg said: “I am excited to join ProFuse Technology’s Scientific Advisory Board and contribute to advancing the ProFuse technology towards therapeutic applications. This collaboration has the potential to significantly improve the lives of many patients suffering from muscle-related diseases.”
Her expertise in materials and methodologies for muscle regeneration and maintenance will be invaluable as we strive to improve patient outcomes for a range of muscle-related diseases.
We at ProFuse are confident that this collaboration will significantly contribute to the development of groundbreaking treatments for conditions like sarcopenia and Duchenne muscular dystrophy.
